Elite Pharmaceuticals (OTCMKTS:ELTP) Stock Passes Above 50-Day Moving Average – Here’s What Happened

Elite Pharmaceuticals Inc. (OTCMKTS:ELTP)’s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.36 and traded as high as $0.3999. Elite Pharmaceuticals shares last traded at $0.3850, with a volume of 387,855 shares traded.

Elite Pharmaceuticals Stock Up 4.1%

The firm has a fifty day simple moving average of $0.36 and a 200 day simple moving average of $0.41. The company has a debt-to-equity ratio of 0.05, a quick ratio of 5.44 and a current ratio of 7.34. The company has a market cap of $414.70 million, a PE ratio of 12.84 and a beta of 0.38.

Elite Pharmaceuticals Company Profile

Elite Pharmaceuticals, Inc is a U.S.-based specialty pharmaceutical company that acquires, develops and markets both branded and generic pharmaceutical products. Headquartered in Houston, Texas, the company focuses on complex dosage forms—including injectables, sterile formulations and oncology therapies—and seeks to address unmet medical needs through advanced drug delivery technologies. Its product portfolio spans therapeutic areas such as pain management, oncology and cardiovascular care.

Since its founding in 2007, Elite Pharmaceuticals has pursued strategic partnerships and licensing agreements to expand its pipeline and manufacturing capabilities.